Your heart has four valves that work hard every day to make sure your blood flows in the right direction. So when a valve becomes weakened due to age, a congenital disability, an infection, or another disease, you may not be feeling your best. If you recently learned you have a heart valve that needs repair or replacement, NewYork-Presbyterian offers you a world-class team of heart specialists who can put together a treatment plan that gets you back on the path to wellness. Their exceptional experience results in extraordinary outcomes in heart valve care.
Our team includes doctors who have led major studies evaluating a novel, less-invasive techniques for repairing and replacing damaged mitral valves, aortic valves, and pulmonary valves. Today our heart valve program is one of the largest of its kind in the country.
We combine the expertise of cardiologists, interventional cardiologists, cardiothoracic surgeons, and cardiac imaging specialists to provide you with high-quality, personalized care.
Virtually every advance in TAVR has had its roots at NewYork-Presbyterian. Our doctors were the principal investigators of the national clinical trials establishing the effectiveness of TAVR, including the PARTNER trial, a landmark study showing that balloon-expandable transcatheter valve replacement in people at high risk for traditional surgery is safe and as effective as open-heart surgery regarding one-year survival.
Our specialists perform the largest volume of valve procedures in the northeastern United States. We've completed more than 2,500 TAVR procedures. Our TAVR program is now among the largest centers in the United States, with more than 550 cases a year and 70 percent of our patients are discharged by the second day. Every heart procedure carries with it some risk, but at NewYork-Presbyterian, our in-hospital mortality rates for valve surgery patients are significantly lower than expected and below national rates.
Our investigators are participating in a number of national clinical trials evaluating new heart valve devices and approaches, including those for people needing aortic valve surgery and mitral valve surgery. We are serving as principal investigators for the multicenter national PARTNER 3 trial assessing TAVR in low-risk patients. You may have the opportunity to participate in a clinical trial of a new heart valve therapy.